Matthew Parnaby

ORCID: 0000-0002-7530-1620
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dermatological diseases and infestations
  • Cultural Competency in Health Care
  • Streptococcal Infections and Treatments
  • Otolaryngology and Infectious Diseases
  • Rabies epidemiology and control
  • Parasites and Host Interactions
  • Hematological disorders and diagnostics
  • Infective Endocarditis Diagnosis and Management
  • Complex Systems and Decision Making
  • Antimicrobial Resistance in Staphylococcus
  • Patient Satisfaction in Healthcare
  • Zoonotic diseases and public health

Murdoch Children's Research Institute
2021-2023

Royal Children's Hospital
2021-2022

Northern Territory Health Services
2013

Government of the Northern Territory
2010

Scabies is a neglected tropical disease (NTD) that causes significant health burden, particularly in disadvantaged communities and where there overcrowding. There emerging evidence ivermectin-based mass drug administration (MDA) can reduce the prevalence of scabies some settings, but remains limited, are no formal guidelines to inform control efforts. An informal World Health Organization (WHO) consultation was organized find agreement on strategies for global control. The resulted framework...

10.1371/journal.pntd.0009661 article EN public-domain PLoS neglected tropical diseases 2021-09-02

Rheumatic heart disease (RHD) remains a major health concern for Aboriginal Australians. A key component of RHD control is prevention recurrent acute rheumatic fever (ARF) using long-term secondary prophylaxis with intramuscular benzathine penicillin (BPG). This the most important and cost-effective step in control. However, there are significant challenges to effective implementation programs. project aimed increase understanding improve quality care through development continuous...

10.1186/1472-6963-13-525 article EN cc-by BMC Health Services Research 2013-12-01

Scabies is an important predisposing factor of impetigo which can lead to serious bacterial complications. Ivermectin-based mass drug administration substantially reduce scabies and prevalence in endemic settings, but the impact on complications not known.We conducted a before-after trial Northern Division Fiji (population: 131,914) for control. Prospective surveillance was from 2018 2020. Mass took place 2019, involving two doses oral ivermectin or topical permethrin, delivered alongside...

10.1016/j.lanwpc.2022.100433 article EN cc-by-nc-nd The Lancet Regional Health - Western Pacific 2022-03-22

In 2019, the Murdoch Children’s Research Institute in partnership with Fiji Ministry of Health and Medical Services carried out an integrated mass drug administration (MDA) for treatment scabies lymphatic filariasis Northern Division (population estimate 131,914). We conducted a retrospective micro-costing exercise focused on cost control order to inform budgeting policy decision making endemic setting. collected detailed information financial economic costs incurred by both parties during...

10.1371/journal.pntd.0010147 article EN cc-by PLoS neglected tropical diseases 2022-02-03

Background Mass drug administration (MDA) based on two doses of ivermectin, one week apart, substantially reduces prevalence both scabies and impetigo. The Regimens Ivermectin for Scabies Elimination (RISE) trial assessed whether one-dose ivermectin-based MDA would be as effective. Methods RISE was a cluster-randomised in Solomon Islands. We assigned 20 villages 1:1 ratio to one- or two-dose MDA. planned test the impact dose at 12 24 months non-inferior two, 5% non-inferiority margin....

10.1371/journal.pntd.0011207 article EN cc-by PLoS neglected tropical diseases 2023-03-17
Coming Soon ...